Literature DB >> 7832223

Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity.

S P Christiansen1, J D Bradford.   

Abstract

PURPOSE: Previous studies of lens opacities occurring after argon laser photocoagulation for retinopathy of prematurity indicate that the lens in these laser-treated eyes may be at risk for cataract. We studied the occurrence of permanent, visually significant cataracts in four infants after laser therapy for retinopathy of prematurity.
METHODS: The records of 51 consecutive patients (100 eyes) treated only with argon laser photocoagulation for threshold retinopathy of prematurity at our institution were reviewed. Patient characteristics and treatment variables were compared between infants who developed cataracts and those who did not.
RESULTS: Complete opacification of the lens nucleus and cortex developed in six eyes of four patients between 19 and 99 days after laser therapy. An additional patient developed a transient, focal, anterior capsular, and subcapsular opacity in one eye that cleared by one month postoperatively. Eyes that developed permanent cataracts were noted to have a prominent anterior tunica vasculosa lentis at the time of treatment. After laser therapy, these eyes developed hyphema, shallowing of the anterior chamber, corneal edema, and progressive opacification of the lens. When compared with eyes that did not develop cataract, no statistically significant difference in number of burns, zone or clock hours of extraretinal proliferation, birth weight, gestational age, or age at treatment was found.
CONCLUSIONS: Cataract is a potential vision-threatening complication of argon laser photocoagulation that must be considered before choosing a treatment modality for infants with threshold retinopathy of prematurity.

Entities:  

Mesh:

Year:  1995        PMID: 7832223     DOI: 10.1016/s0002-9394(14)73870-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

Review 1.  Laser treatment for retinopathy of prematurity.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2011-12-02       Impact factor: 3.161

2.  Computer-assisted quantification of vascular tortuosity in retinopathy of prematurity (an American Ophthalmological Society thesis).

Authors:  David K Wallace
Journal:  Trans Am Ophthalmol Soc       Date:  2007

3.  Diode laser photocoagulation for retinopathy of prematurity.

Authors:  T Tsitsis; W Tasman; J A McNamara; G Brown; J Vander
Journal:  Trans Am Ophthalmol Soc       Date:  1997

4.  Transscleral diode laser photocoagulation for type 1 prethreshold retinopathy of prematurity.

Authors:  Mohammad Mehdi Parvaresh; Khalil Ghasemi Falavarjani; Mehdi Modarres; Hossein Nazari; Nahid Saiepour
Journal:  J Ophthalmic Vis Res       Date:  2013-10

5.  Incidence of cataract development by 6 months' corrected age in the Early Treatment for Retinopathy of Prematurity study.

Authors:  Bradley V Davitt; Stephen P Christiansen; Robert J Hardy; Betty Tung; William V Good
Journal:  J AAPOS       Date:  2013-01-23       Impact factor: 1.220

6.  Long term visual outcomes in laser treated threshold retinopathy of prematurity in Central Saudi Arabia.

Authors:  Abdullah G Al-Otaibi; Sultan S Aldrees; Ahmed A Mousa
Journal:  Saudi J Ophthalmol       Date:  2012-06-07

Review 7.  Cataract in retinopathy of prematurity - A review.

Authors:  Sudarshan Khokhar; Abhidnya Surve; Saurabh Verma; Shorya Azad; Parijat Chandra; Chirakshi Dhull; Rajpal Vohra
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

8.  Safety and efficacy of 532 nm frequency-doubled Nd-YAG green laser photocoagulation for treatment of retinopathy of prematurity.

Authors:  Simar Rajan Singh; Deeksha Katoch; Sabia Handa; Savleen Kaur; Bruttendu Moharana; Mohit Dogra; Mangat R Dogra
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.